Thomas Jefferson University Research Facility — Philadelphia, Pennsylvania

Thomas Jefferson University Research Facility is a clinical research site located in Philadelphia, Pennsylvania, United States 19107.

Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.

Thomas Jefferson University Research Facility has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Non-Small Cell Lung Cancer, NSCLC, EGFR/HER2 Exon 20 Insertion Mutation.

Sponsors: Pierre Fabre Medicament.

Sponsor Feasibility Report

Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Thomas Jefferson University Research Facility?

Thomas Jefferson University Research Facility has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Thomas Jefferson University Research Facility conducted?

Thomas Jefferson University Research Facility has 1 clinical trials on record, with 1 currently active. Their work covers Non-Small Cell Lung Cancer, NSCLC, EGFR/HER2 Exon 20 Insertion Mutation.

Is Thomas Jefferson University Research Facility accredited by Crixeo Health?

Thomas Jefferson University Research Facility has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Thomas Jefferson University Research Facility?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.